Genprex
is a Texas-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of cancer and diabetes... Read moreGenprex
is a Texas-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of cancer and diabetes... Read more
News
Mar 10, 2026
PR Newswire
Press Release: Genprex : Genprex to Participate at BIO Europe Spring 2026
Feb 26, 2026
Indian Pharma Post
Genprex: Genprex bags major patent wins in Japan & Europe for REQORSA cancer therapy
Feb 23, 2026
Investing.com
Genprex: Genprex stock jumps on Japan, Europe patent approvals By Investing.com
Feb 23, 2026
Genprex Blog
Genprex Blog Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa Gene Therapy in Combination with Immunotherapies to Treat Cancer
Jan 07, 2026
Nasdaq
Genprex: Genprex Advances Diabetes Gene Therapy Program With Preclinical Milestones
Nov 24, 2025
StreetInsider
Press Release: Genprex : Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer
Nov 18, 2025
Genprex Blog
Genprex Blog Genprex Announces U.S. Patent for Reqorsa Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Nov 14, 2025
Marketscreener
Genprex: Genprex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
Nov 04, 2025
Genprex Blog
Genprex Blog Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa Gene Therapy and PD-1 Antibodies to Treat Cancer
Oct 28, 2025
Genprex Blog
Genprex Blog Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
Genprex Competitors
1
2
3
4
5